Clinical Trials Browser

Phase 2 × Carcinoma, Transitional Cell × MLN 8237 × Clear all

NCT02109328 2019-04-11

Alisertib in Chemotherapy-pretreated Urothelial Cancer

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell